Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ARPC1B binds WASP to control actin polymerization and curtail tonic signaling in B cells
Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman
Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman
View: Text | PDF
Research Article Cell biology Immunology

ARPC1B binds WASP to control actin polymerization and curtail tonic signaling in B cells

  • Text
  • PDF
Abstract

Immune cells exhibit low-level, constitutive signaling at rest (tonic signaling). Such tonic signals are required for fundamental processes, including the survival of B lymphocytes, but when they are elevated by genetic or environmental causes, they can lead to autoimmunity. Events that control ongoing signal transduction are, therefore, tightly regulated by submembrane cytoskeletal polymers like F-actin. The actin-binding proteins that underpin the process, however, are poorly described. By investigating patients with ARPC1B deficiency, we report that ARPC1B-containing ARP2/3 complexes are stimulated by Wiskott Aldrich Syndrome protein (WASP) to nucleate the branched actin networks that control tonic signaling from the B cell receptor (BCR). Despite an upregulation of ARPC1A, ARPC1B-deficient cells were not capable of WASP-mediated nucleation by ARP2/3, and this caused the loss of WASP-dependent structures, including podosomes in macrophages and lamellipodia in B cells. In the B cell compartment, ARPC1B deficiency also led to weakening of the cortical F-actin cytoskeleton that normally curtails the diffusion of BCRs and ultimately resulted in increased tonic lipid signaling, oscillatory calcium release from the endoplasmic reticulum (ER), and phosphorylated Akt. These events contributed to skewing the threshold for B cell activation in response to microbial-associated molecular patterns (MAMPs). Thus, ARPC1B is critical for ARP2/3 complexes to control steady-state signaling of immune cells.

Authors

Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman

×

Figure 2

WASP binds to the ARPC1B subunit of the ARP2/3 complex to stimulate its nucleation.

Options: View larger image (or click on image) Download as PowerPoint
WASP binds to the ARPC1B subunit of the ARP2/3 complex to stimulate its ...
(A) Representative plots of actin polymerization assays in ARPC1B-deficient patient and control LCLs. Samples with pyrene-actin alone were recorded from t = –5 to 0 minutes to establish a baseline. Standardized whole cell lysates together with ATP and actin polymerization buffer ± VCA ± CK-666 (or vehicle controls) were added at t = 0 minutes and recorded every minute for 1 hour. Data are standardized as a fold change over the relative fluorescence units (RFU) at t = –5 minutes and represented as the mean ± SEM. (B) Data were analyzed as a plateau (maximal activity) followed by 1 phase association. The actin polymerization rate constants and activity maxima were calculated, normalized to the unstimulated sample within each sample, and represented as 2.5–97.5 percentile box plots; n > 4. For each data set, a 2-way ANOVA was performed followed by a Tukey’s multiple-comparison test; significance represents the comparison between VCA and VCA + CK-666 within the same sample. See also Supplemental Figure 2. (C) WT (control) and ARPC1B-KO Ramos B cells on anti-IgM–coated coverslips for 20 minutes, stained with Alexa Fluor 488–phalloidin (F-actin) (left). Scale bar: 10 μm. Contact surface area (μm2) was measured for 3–5 fields containing > 5 cells (right); n = 5. (D and E) Representative coimmunoprecipitation blots performed in HEK-293 cells. (D) Lysates from cells overexpressing full-length WT human WASP and ARPC1B or ARPC1A constructs were pulled down with FLAG beads (WASP); n = 4. (E) Representative blot showing samples immunoprecipitated using V5 beads (ARPC1B or ARPC1A); n = 6. (F) Densitometry analysis of ARPC1B and ARPC1A expression in cell lysates and pull-down proteins; n = 7. IP densitometry was compared using Student’s unpaired 2-tailed t test. Lysate densitometry was compared using a 1-way ANOVA with Tukey’s multiple-comparison test. Data are represented as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts